This week on Contemporary OB/GYN®: Oct. 25 to Oct. 29
Here's a preview of what to expect this week from Contemporary OB/GYN®.
Pink October video shines light on women’s health — and their right to know prices
Every October, the pink ribbons and flamingoes come out to raise breast cancer awareness. However, Pink October should go beyond breast cancer awareness to shine the light on women’s health overall, and, as important, the huge responsibility women bear as chief decision-makers for their families’ health care.
Agenus Withdraws BLA for Balstilimab in Metastatic Cervical Cancer
The immuno-oncology company Agenus has made the decision to withdraw its biologic license application for the use of the PD-1 inhibitor balstilimab in patients with recurrent or metastatic cervical cancer who experienced disease progression on, or after, chemotherapy.
Poll: Have you attended an in-person conference recently?
Check back soon for additional updates.
FDA approves Visby’s test for at-home STI identification
Published: March 28th 2025 | Updated: March 28th 2025The FDA has approved Visby Medical’s at-home sexually transmitted infection test, allowing women to screen for chlamydia, gonorrhea, and trichomoniasis without a prescription.
Read More
